INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
The Indian pharmaceutical industry is a rapidly growing sector that is expected to reach a value of US$130 billion by 2025.The pharmaceutical industry is experiencing a transformative shift in its marketing paradigm, with an increasing focus on Direct-to-Consumer (D2C) strategies. Direct-to-consumer (D2C) marketing is a growing trend in the industry that is having a significant impact on the way pharmaceutical companies reach and engage with consumers.D2C marketing allows pharmaceutical companies to bypass traditional channels such as pharmacies and doctors, and directly connect with consumers online and through other channels. This approach has several advantages, including increased brand awareness, greater control over the customer experience, and reduced costs. As traditional marketing channels evolve, pharmaceutical companies are increasingly embracing D2C approaches to engage with patients and consumers directly. The article examines the multifaceted impact of D2C marketing on the industry, including enhanced patient awareness, changing dynamics of healthcare communication, regulatory challenges, and the evolution of brand-consumer relationships. Through a thorough analysis of case studies, industry trends, and regulatory frameworks, this review provides valuable insights into the opportunities and challenges posed by the integration of D2C marketing in the pharmaceutical sector. The synthesis of existing literature and empirical evidence aims to guide future research and strategic decision-making, fostering a deeper understanding of the implications of D2C marketing for both pharmaceutical companies and healthcare consumers. The article also addresses the regulatory complexities and ethical considerations surrounding D2C marketing in the pharmaceutical sector and underscores the need for a balance between information accessibility and patient safety, emphasizing the importance of stringent guidelines to govern the content and delivery of D2C campaigns.The analysis delves into the evolving regulatory landscape, technological advancements, and changing consumer behaviors that have spurred the adoption of D2C marketing within the industry
"Impact of D2C Market In Pharma Industry ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 3, page no.b623-b633, March-2024, Available :http://www.ijnrd.org/papers/IJNRD2403169.pdf
Downloads:
000121
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn